子宫内膜癌组织NF-κB、STAT3蛋白对子宫内膜癌的诊断及预后价值意义分析

摘要/Abstract

摘要： 目的探讨与分析子宫内膜癌（EC）组织核因子κB（NF-κB）、信号转导与转录激活因子3（STAT3）蛋白对子宫内膜癌的诊断及预后价值意义。方法选择2019年9月—2022年11月石河子大学第一附属医院收治的88例子宫内膜癌患者作为研究对象,取所有患者术中切除的新鲜子宫内膜癌肿瘤组织标本（肿瘤组）和癌旁正常子宫内膜组织（癌旁组）,采用免疫组化法检测NF-κB、STAT3蛋白表达阳性率,调查患者的病理特征、随访预后并进行相关性分析。结果肿瘤组NF-κB、STAT3蛋白表达阳性率显著高于癌旁组,差异具有统计学意义（P<0.05）。在88例患者中,不同年龄、临床分期、分化程度、肌层浸润、淋巴结转移患者的NF-κB、STAT3蛋白表达阳性率比较,差异具有统计学意义（P<0.05）。所有患者随访到2023年6月1日,生存患者NF-κB、STAT3蛋白表达阳性率明显低于死亡患者,差异具有统计学意义（P<0.05）。Cox回归分析显示NF-κB、STAT3蛋白表达阳性率为影响预后中位生存时间的重要因素,差异有统计学意义（P<0.05）。结论子宫内膜癌组织多伴随有NF-κB、STAT3蛋白的高表达,其表达水平与患者的临床病理特征和预后生存情况都存在相关性。

关键词: 子宫内膜癌, 核因子κB, 信号转导与转录激活因子3, 病理特征, 中位生存时间, 相关性

Abstract: Objective To explore and analysis the diagnostic and prognostic significance of nuclear factor κB (NF-κB) and signal transducer and activator of transcription 3 (STAT3) proteins in endometrial cancer (EC) tissue. Method From September 2019 to November 2022, 88 cases of patients with endometrial cancer who were diagnosed and treated in The First Affiliated Hospital of Shihezi University were selected as the research subjects. Fresh endometrial cancer tumor tissue samples (tumor group) and normal endometrial tissue adjacent to cancer (adjacent group) were taken from all patients who underwent surgery, and the NF-κB, STAT3 proteins were detected using immunohistochemistry, investigated the pathological characteristics of patients, followed up prognosis, and conducted correlation analysis. Result The positive rates of NF-κB and STAT3 proteins in the tumor group were 63.64% and 56.82%, and were 15.91% and 13.64% in the adjacent cancer group that the tumor group were significantly higher than the adjacent cancer group (P<0.05). In the 88 patients, There were significant difference in the positive rate of NF-κB and STAT3 protein expression in the different age, clinical stage, degree of differentiation, muscle infiltration, and lymph node metastasis patients (P<0.05). All patients were followed up until June 1, 2023, the positive rate of NF-κB and STAT3 protein expression in the surviving patients were significantly lower than that of death patients (P<0.05). Cox regression analysis showspositive rate of NF-κB and STAT3 protein expression were the important factor affected the median survival time of prognosis (P<0.05). Conclusion Endometrial cancer tissue are often accompanied by the high expression of NF-κB and STAT3, and are correlated with the clinical pathological characteristics and prognosis of patients.

Key words: endometrial cancer, nuclear factor κB, signal transduction and transcription activating factor 3, pathological characteristics, median survival time, relativity

中图分类号:

R737.33

梁伟华, 张海俊, 裴学莲. 子宫内膜癌组织NF-κB、STAT3蛋白对子宫内膜癌的诊断及预后价值意义分析[J]. 中华养生保健, 2024, 42(6): 12-16.

LIANG Wei-hua, ZHANG Hai-jun, PEI Xue-lian. The Diagnostic and Prognostic Significance of Nuclear Factor KB and Signal Transducer and Activator of Transcription 3 Proteins in Endometrial Cancer Tissue[J]. ZHONGHUA YANGSHENG BAOJIAN, 2024, 42(6): 12-16.

参考文献

[1] 时周云,陈红晶,钱琳玉,等.SEMA3F通过CXCR4/JAK2/STAT3通路抑制子宫内膜癌细胞增殖、侵袭、迁移及血管生成[J].现代肿瘤医学,2023,31(7):1218-1225.
[2] 梁秀兰,邱红兵,郑玉丹.老年子宫内膜癌患者组织中环氧合酶2、NF-κB、STAT3表达及意义[J].中国老年学杂志,2022,42(14):3577-3580.
[3] 张莉,周丽,唐艳,万朝霞.吴茱萸碱对子宫内膜癌细胞EMT及JAK/STAT3/HIF-1α通路的影响[J].世界科学技术-中医药现代化,2022,24(9):3516-3523.
[4] 康丽荣,张林爱,张婧,等.宝藿苷Ⅰ诱导子宫内膜癌线粒体依赖性凋亡的机制研究[J].中华内分泌外科杂志,2022,16(3):330-334.
[5] 季剑乐,王力杰.微小RNA-126和STAT3在子宫内膜癌中的表达及临床意义[J].中国妇幼保健,2022,37(17):3250-3254.
[6] 汪洁,杨彩凤,吴亚凡,等.雷公藤甲素通过STAT3/PD-L1通路介导子宫内膜癌KLE细胞DNA损伤诱导细胞凋亡的作用机制研究[J].中医药导报,2022,28(3):13-17.
[7] 翟爱丽,魏旭静,朱继红,等.下调miR-675-5p对子宫内膜癌细胞侵袭、迁移影响及机制研究[J].中国优生与遗传杂志,2021,29(4):444-448.
[8] 徐信,薛晓鸥,宗春晓,等.基于网络药理学联合GEO芯片探讨金雀异黄素治疗子宫内膜癌的机制[J].湖南中医药大学学报,2021,41(1):116-122.
[9] 董莹莹,李威.紫草素对子宫内膜癌Ishikawa细胞生物学行为的影响及可能机制[J].解剖科学进展,2021,27(1):39-41.
[10] 阮晓红,钟媚共,刘婉敏,等.过表达白血病抑制因子增强子宫内膜癌细胞对化疗药物的耐受[J].南方医科大学学报,2020,40(1):20-26.
[11] 陈海伦,宏小翠,胡克辉,等.信号传导及转录活化因子3和X连锁凋亡抑制蛋白在肿瘤组织的表达及其临床意义[J].中华实验外科杂志,2020,37(12):2341-2343.
[12] 秦春艳. miR-129-5p和STAT3在子宫内膜癌组织中的表达及临床意义[J].现代肿瘤医学,2020,28(16):2870-2875.
[13] 车祺,刘素英,董曦.白细胞介素-6和磷酸化信号转导和转录激活因子3在子宫内膜癌中的表达及相关性研究[J].癌症进展,2020,18(19):2030-2032,2045.
[14] 杨菲,王静丽,范丽丝.子宫内膜癌组织中miR-21、STAT3、FOXO3a的表达及临床意义[J].热带医学杂志,2020,20(8):1074-1078.
[15] 姚文娟,宋会双,王凤琴,等.IL-6、STAT3在子宫内膜癌中的表达及与临床特征的关系[J].癌症进展,2019,17(22):2645-2647.
[16] 肖庆,刘莉,胡雅君,等.miR-125b-5p靶向STAT3调控免疫因子IL-6/10的表达抑制子宫内膜癌细胞的增殖、迁移和侵袭的机制研究[J].免疫学杂志,2019,35(7):553-560.
[17] 陈闻月. miR-124靶向STAT3抑制子宫内膜癌增殖和侵袭的机制研究[J].中国妇幼保健,2019,34(22):5295-5297.
[18] 陈悦群,翟洪波,仝进毅,等.竹节香附素通过抑制JAK/STAT3信号转导通路抑制人子宫内膜癌HEC-1-B细胞的侵袭转移[J].中国临床药理学与治疗学,2019,24(4):391-396.
[19] 李少儒,王世进,户瑞丽,等.RNA干扰HDAC1对子宫内膜癌细胞迁移和侵袭的影响[J].癌症进展,2019,17(1):105-108,119.
[20] 杨翠英,张红梅.转录因子GATA6和STAT4在子宫内膜癌中的表达及临床意义[J].中国妇幼保健,2019,34(16):3817-3821.